Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer
William A. Freed-Pastor, Laurens J. Lambert, Zackery A. Ely, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1342-1360.e14
Open Access | Times Cited: 188

Showing 1-25 of 188 citing articles:

Pancreatic cancer: Advances and challenges
Christopher J. Halbrook, Costas A. Lyssiotis, Marina Pasca di Magliano, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1729-1754
Open Access | Times Cited: 554
Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment
William L. Hwang, Karthik A. Jagadeesh, Jimmy A. Guo, et al.
Nature Genetics (2022) Vol. 54, Iss. 8, pp. 1178-1191
Open Access | Times Cited: 231
Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
Marta Łuksza, Zachary Sethna, Luis A. Rojas, et al.
Nature (2022) Vol. 606, Iss. 7913, pp. 389-395
Open Access | Times Cited: 136
TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy
Eugene Y. Chiang, Ira Mellman
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 4, pp. e004711-e004711
Open Access | Times Cited: 124
Nanomaterials in tumor immunotherapy: new strategies and challenges
Xudong Zhu, Shenglong Li
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 110
Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment
Gregor Werba, Daniel Weissinger, Emily Kawaler, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 107
Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
Chiara Falcomatà, Stefanie Bärthel, Günter Schneider, et al.
Cancer Discovery (2023) Vol. 13, Iss. 2, pp. 278-297
Open Access | Times Cited: 99
Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials
Xianjing Chu, Wentao Tian, Ziqi Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 90
The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 70
Impact of risk factors on early cancer evolution
Clare E. Weeden, William Hill, Emilia L. Lim, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1541-1563
Open Access | Times Cited: 63
Analysis of Donor Pancreata Defines the Transcriptomic Signature and Microenvironment of Early Neoplastic Lesions
Eileen S. Carpenter, Ahmed M. Elhossiny, Padma Kadiyala, et al.
Cancer Discovery (2023) Vol. 13, Iss. 6, pp. 1324-1345
Open Access | Times Cited: 60
Lymphocyte networks are dynamic cellular communities in the immunoregulatory landscape of lung adenocarcinoma
Giorgio Gaglia, Megan L. Burger, Cecily C. Ritch, et al.
Cancer Cell (2023) Vol. 41, Iss. 5, pp. 871-886.e10
Open Access | Times Cited: 51
Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy
Stefanie Bärthel, Chiara Falcomatà, Roland Rad, et al.
Nature Cancer (2023) Vol. 4, Iss. 4, pp. 454-467
Open Access | Times Cited: 50
Novel strategies for cancer immunotherapy: counter-immunoediting therapy
Shaochuan Liu, Qian Sun, Xiubao Ren
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 49
Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation
Kangchun Wang, Xin Wang, Qi Pan, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 47
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Targeting TIGIT for cancer immunotherapy: recent advances and future directions
Peng Zhang, Xinyuan Liu, Zhuoyu Gu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 32
Advances and prospects of biomarkers for immune checkpoint inhibitors
Hirohito Yamaguchi, Jung-Mao Hsu, Linlin Sun, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 7, pp. 101621-101621
Open Access | Times Cited: 30
Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Wenyu Luo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 24
Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities
Nanhao Yin, Xintong Li, Xuanwei Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets
Greta Pessino, Claudia Scotti, Maristella Maggi
Cancers (2024) Vol. 16, Iss. 5, pp. 901-901
Open Access | Times Cited: 19
Digestive cancers: mechanisms, therapeutics and management
Tianzuo Zhan, Johannes Betge, Nadine Schulte, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx® Digital Spatial Profiler
Helga Bergholtz, Jodi M. Carter, Alessandra Cesano, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4456-4456
Open Access | Times Cited: 74
Deciphering the immunopeptidome in vivo reveals new tumour antigens
Alex M. Jaeger, Lauren Stopfer, Ryuhjin Ahn, et al.
Nature (2022) Vol. 607, Iss. 7917, pp. 149-155
Open Access | Times Cited: 66
Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer
Pat Gulhati, Aislyn Schalck, Shan Jiang, et al.
Nature Cancer (2022)
Open Access | Times Cited: 64
Page 1 - Next Page

Scroll to top